The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase

Rationale: Resistance to pemetrexed (PEM)-based chemotherapy is a major cause of progression in non-small cell lung cancer (NSCLC) patients. The deubiquitinating enzyme UCHL1 was recently found to play important roles in chemoresistance and tumor progression. However, the potential roles and mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Xinyuan, Gu, Yuting, Jin, Min, Guo, Xin, Xue, Sudong, Tan, Caihong, Huang, Jiefang, Yang, Wanlin, Xue, Mingxing, Zhou, Qianjun, Wang, Wenjuan, Zhang, Yanyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255002/
https://www.ncbi.nlm.nih.gov/pubmed/32483437
http://dx.doi.org/10.7150/thno.42096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255002/
https://www.ncbi.nlm.nih.gov/pubmed/32483437
http://dx.doi.org/10.7150/thno.42096

Ejemplares similares